NSABP Members' Area
  Password Protected - Access
  Limited to NSABP Participating
  Institutions Only

NSABP Foundation, Inc.

General NSABP Information
  Financial Conflicts of
     Interest Policy
  Coalition Comment:
  IOM Report Group Comment
  Contact the NSABP
  Pathology Section
  Future Meetings
  NSABP Newsletters
  Media Info on STAR

Clinical Trials Information
  Clinical Trials Overview
  Protocol Chart
  Never Say Lost

Treatment Trials Information
  Protocol B-51
  Protocol B-52
  Protocol B-53/S1207
  Protocol B-55/BIG 6-13

Prevention Trials Information
  Protocol P-1 - BCPT
  Protocol P-2 - STAR

Scientific Publications

Related Web Sites

Medical Search Engines

To report problems, ask
questions or make comments,
please send e-mail to:

Annotated Bibliography of NSABP Publications

NSABP B-35: A Clinical Trial to Compare Anastrozole and Tamoxifen for Postmenopausal Patients with Ductal Carcinoma In Situ Undergoing Lumpectomy with Radiation Therapy
Julian TB, Land SR, Wolmark N
Breast Diseases: A Year Book Quarterly 2003;14(2):121-122

Results from 2 previous trials by the National Surgical Adjuvant Breast and Bowel Project (NSABP) have clarified several controversial issues about the nature of ductal carcinoma in situ (DCIS) and have provided alternative approaches for managing this disease. The B-17 trial compared outcomes among women with DCIS treated with lumpectomy vs with lumpectomy plus radiation therapy; the B-24 trial evaluated the addition of tamoxifen to lumpectomy plus radiation therapy.